Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael C Gong

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Urologic Oncology|July 29, 2008
Preoperative hydronephrosis as an indicator of survival after radical cystectomyDarren M Chapman, Kamal S Pohar, Michael C Gong, et al.
The Journal of Urology|December 17, 2009
How do commonly performed lymphadenectomy templates influence bladder cancer nodal stage?Pankaj P Dangle, Michael C Gong, Robert R Bahnson, et al.
World Journal of Urology|May 21, 2003
Tomatoes, lycopene and prostate cancer: a clinician's guide for counseling those at risk for prostate cancerKamal S Pohar, Michael C Gong, Robert Bahnson, et al.
The Journal of Urology|February 21, 2012
Quality of lymphadenectomy is equivalent with robotic and open cystectomy using an extended templateRonney Abaza, Pankaj P Dangle, Michael C Gong, et al.
Expert Review of Anticancer Therapy|July 14, 2007
Prostate-sparing cystectomy: has Pandora's box been opened?John C Kefer, Edward E Cherullo, J Stephen Jones, et al.
Urology|October 13, 2009
Aggregate lymph node metastasis diameter and survival after radical cystectomy for invasive bladder cancerAndrew J Stephenson, Michael C Gong, Steven C Campbell, et al.
Gynecologic Oncology|November 29, 2007
Panniculectomy concurrent with anterior pelvic exenteration for recurrent cervical cancerDebra L Richardson, Leigh G Seamon, Michael C Gong, et al.
The Journal of Urology|August 19, 2011
Presacral and retroperitoneal lymph node involvement in urothelial bladder cancer: results of a prospective mapping studyRanko Miocinovic, Michael C Gong, Islam A Ghoneim, et al.
Urology|June 21, 2011
Utility of percent free prostate-specific antigen in repeat prostate biopsyByron H Lee, Adrian V Hernandez, Osama Zaytoun, et al.
European Urology|July 22, 2008
Analysis of T1c prostate cancers treated at very low prostate-specific antigen levelsAndrew J Stephenson, J Stephen Jones, Adrian V Hernandez, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Urologic Oncology|July 29, 2008
Preoperative hydronephrosis as an indicator of survival after radical cystectomyDarren M Chapman, Kamal S Pohar, Michael C Gong, et al.
The Journal of Urology|December 17, 2009
How do commonly performed lymphadenectomy templates influence bladder cancer nodal stage?Pankaj P Dangle, Michael C Gong, Robert R Bahnson, et al.
World Journal of Urology|May 21, 2003
Tomatoes, lycopene and prostate cancer: a clinician's guide for counseling those at risk for prostate cancerKamal S Pohar, Michael C Gong, Robert Bahnson, et al.
The Journal of Urology|February 21, 2012
Quality of lymphadenectomy is equivalent with robotic and open cystectomy using an extended templateRonney Abaza, Pankaj P Dangle, Michael C Gong, et al.
Expert Review of Anticancer Therapy|July 14, 2007
Prostate-sparing cystectomy: has Pandora's box been opened?John C Kefer, Edward E Cherullo, J Stephen Jones, et al.
Urology|October 13, 2009
Aggregate lymph node metastasis diameter and survival after radical cystectomy for invasive bladder cancerAndrew J Stephenson, Michael C Gong, Steven C Campbell, et al.
Gynecologic Oncology|November 29, 2007
Panniculectomy concurrent with anterior pelvic exenteration for recurrent cervical cancerDebra L Richardson, Leigh G Seamon, Michael C Gong, et al.
The Journal of Urology|August 19, 2011
Presacral and retroperitoneal lymph node involvement in urothelial bladder cancer: results of a prospective mapping studyRanko Miocinovic, Michael C Gong, Islam A Ghoneim, et al.
Urology|June 21, 2011
Utility of percent free prostate-specific antigen in repeat prostate biopsyByron H Lee, Adrian V Hernandez, Osama Zaytoun, et al.
European Urology|July 22, 2008
Analysis of T1c prostate cancers treated at very low prostate-specific antigen levelsAndrew J Stephenson, J Stephen Jones, Adrian V Hernandez, et al.
Pageof 2